Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.
B. Winblad;K. Palmer;Miia Kivipelto;V. Jelic.
Journal of Internal Medicine (2004)
Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
Yvonne Freund-Levi;Maria Eriksdotter-Jönhagen;Tommy Cederholm;Hans Basun.
JAMA Neurology (2006)
Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease'
Peter Davies;Judith Resnick;Burton Resnick;Sid Gilman.
Neurobiology of Aging (1998)
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
Pieter Jelle Visser;Pieter Jelle Visser;Frans Verhey;Dirk L Knol;Philip Scheltens.
Lancet Neurology (2009)
Intracerebroventricular Infusion of Nerve Growth Factor in Three Patients with Alzheimer’s Disease
Maria Eriksdotter Jönhagen;Agneta Nordberg;Kaarina Amberla;Lars Bäckman.
Dementia and Geriatric Cognitive Disorders (1998)
Association of gait and balance disorders with age-related white matter changes The LADIS Study
H. Baezner;C. Blahak;A. Poggesi;L. Pantoni.
Neurology (2008)
Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values.
Magnus Sjögren;Hugo Vanderstichele;Hans Ågren;Olof Zachrisson.
Clinical Chemistry (2001)
Impact of Age-Related Cerebral White Matter Changes on the Transition to Disability – The LADIS Study: Rationale, Design and Methodology
Leonardo Pantoni;Anna Maria Basile;Giovanni Pracucci;Kjell Asplund.
Neuroepidemiology (2005)
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease
Madhav Thambisetty;Andrew Simmons;Latha Velayudhan;Abdul Hye.
Archives of General Psychiatry (2010)
Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort
Domenico Inzitari;Giovanni Pracucci;Anna Poggesi;Giovanna Carlucci.
BMJ (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Karolinska Institute
King's College London
Aristotle University of Thessaloniki
Amsterdam UMC
University of Eastern Finland
University of Oxford
University of Helsinki
University of Gothenburg
Karolinska Institute
Karolinska Institute
New York University
University of Trento
University of Edinburgh
University of Cologne
University of Pittsburgh
Spanish National Research Council
Federal University of Rio Grande do Sul
University of Giessen
Rochester Regional Health
KU Leuven
Erasmus University Rotterdam
Liverpool School of Tropical Medicine
Mayo Clinic
Florey Institute of Neuroscience and Mental Health
Federal Reserve System
Thomas Jefferson University